These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2167575)

  • 1. [Use of electroconvulsive therapy for breaking the continual course of drug-resistant affective and schizoaffective psychoses].
    Mosolov SN; Moshchevitin SIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(4):121-5. PubMed ID: 2167575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of mania: a naturalistic study of electroconvulsive therapy versus lithium in 438 patients.
    Black DW; Winokur G; Nasrallah A
    J Clin Psychiatry; 1987 Apr; 48(4):132-9. PubMed ID: 3104316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preventive treatment of affective psychoses with finlepsin].
    Vovin RIa; Digilov AG; Skorik AI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(8):1226-30. PubMed ID: 6495947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance electroconvulsive therapy for recurrent refractory mania.
    Nascimento AL; Appolinario JC; Segenreich D; Cavalcanti MT; Brasil MA
    Bipolar Disord; 2006 Jun; 8(3):301-3. PubMed ID: 16696835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative evaluation of clinical and economic effectiveness of preventive therapy of affective and schizoaffective psychoses].
    Ushakov IuV; Kostiukova EG; Kalugina LI; Mirzoian MG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(9):79-82. PubMed ID: 2176049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of electroconvulsive therapy in resistant states of affective and schizoaffective structure within the framework of endogenous psychoses].
    Moshchevitin SIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(12):68-73. PubMed ID: 3245380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurence of ultra-rapid cycling during electroconvulsive therapy in bipolar depression.
    Zavorotnyy M; Diemer J; Patzelt J; Behnken A; Zwanzger P
    World J Biol Psychiatry; 2009; 10(4 Pt 3):987-90. PubMed ID: 19172530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative characteristics of the preventive properties of short-acting and delayed-action lithium carbonate in endogenous affective psychoses].
    Panteleeva GP; Mikhaĭlova NM; Beliaev BS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(3):406-12. PubMed ID: 6789585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroconvulsive therapy: an effective therapy of medication-resistant bipolar disorder.
    Sienaert P; Peuskens J
    Bipolar Disord; 2006 Jun; 8(3):304-6. PubMed ID: 16696836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of bipolar disorder: how far have we come?
    Hopkins HS; Gelenberg AJ
    Psychopharmacol Bull; 1994; 30(1):27-38. PubMed ID: 7972626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of lithium continuation therapy in depressed patients who have responded to electroconvulsive therapy.
    Shapira B; Gorfine M; Lerer B
    Convuls Ther; 1995 Jun; 11(2):80-5. PubMed ID: 7552058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients.
    Placidi GF; Lenzi A; Lazzerini F; Cassano GB; Akiskal HS
    J Clin Psychiatry; 1986 Oct; 47(10):490-4. PubMed ID: 3093468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance ECT in intractable manic-depressive disorders.
    Vanelle JM; Loo H; Galinowski A; de Carvalho W; Bourdel MC; Brochier P; Bouvet O; Brochier T; Olie JP
    Convuls Ther; 1994 Sep; 10(3):195-205. PubMed ID: 7834256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study.
    Odeberg H; Rodriguez-Silva B; Salander P; Mårtensson B
    J ECT; 2008 Sep; 24(3):183-90. PubMed ID: 18695624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A seasonal schedule for maintenance ECT.
    Kramer BA
    J ECT; 1999 Sep; 15(3):226-31. PubMed ID: 10492862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
    Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
    J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carbamazepine in the treatment of mania and prevention of recurrence of manic-depressive disorders].
    Finzen A
    Psychiatr Prax; 1991 Jan; 18(1):1-8. PubMed ID: 2027912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative effectiveness of preventive use of lithium carbonate, carbamazepine and sodium valproate in affective and schizoaffective psychoses].
    Mosolov SN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(4):78-83. PubMed ID: 1650105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.